CAS 2734168-45-5

Pyrazino[2,1-c][1,4]benzoxazine, 8-[5-(2-fluoro-6-methoxyphenyl)-1H-pyrazolo[4,3-d]pyrimidin-3-yl]-1,2,3,4,4a,5-hexahydro-3-methyl-

Description:

Pyrazino[2,1-c][1,4]benzoxazine derivatives, such as the compound with the CAS number 2734168-45-5, typically exhibit a complex molecular structure characterized by a fused bicyclic system that includes both pyrazine and benzoxazine moieties. This compound features a hexahydro structure, indicating the presence of a saturated ring system, which contributes to its stability and potential biological activity. The presence of a 2-fluoro-6-methoxyphenyl group and a pyrazolo[4,3-d]pyrimidin-3-yl substituent suggests that the compound may possess interesting pharmacological properties, potentially acting as a bioactive agent in medicinal chemistry. Such compounds are often investigated for their roles in various therapeutic areas, including anti-cancer and anti-inflammatory applications. The specific interactions and reactivity of this compound would depend on its functional groups and overall molecular conformation, which can influence its solubility, bioavailability, and mechanism of action. Further studies, including in vitro and in vivo evaluations, would be necessary to fully elucidate its characteristics and potential uses.

Formula: C₂₄H₂₃FN₆O₂

Synonyms:

• Pyrazino[2,1-c][1,4]benzoxazine, 8-[5-(2-fluoro-6-methoxyphenyl)-1H-pyrazolo[4,3-d]pyrimidin-3-yl]-1,2,3,4,4a,5-hexahydro-3-methyl-
• HPK1-IN-14

HPK1-IN-14

CAS: 2734168-45-5

HPK1-IN-14 is a potent inhibitor of HPK1. HPK1-IN-14 has potential for the study of HPK1-related diseases.

Formula: C₂₄H₂₃FN₆O₂

Color and Shape: Solid

Molecular weight: 446.48

Ref: TM-T62645